1. A multicenter, single‐arm, open‐label, phase 2 study of apitolisib (GDC‐0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study). Issue 22 (7th September 2016) Authors: Makker, Vicky; Recio, Fernando O.; Ma, Ling; Matulonis, Ursula A.; Lauchle, Jennifer O.; Parmar, Hema; Gilbert, Houston N.; Ware, Joseph A.; Zhu, Rui; Lu, Shan; Huw, Ling‐Yuh; Wang, Yulei; Koeppen, Hartmut; Spoerke, Jill M.; Lackner, Mark R.; Aghajanian, Carol A. Journal: Cancer Issue: Volume 122:Issue 22(2016) Page Start: 3519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗